MedPath

The Use of Wireless Sensors in Neonatal Intensive Care

Active, not recruiting
Conditions
Preterm Birth
Apnea of Newborn
Interventions
Device: ANNE™ Monitoring System (2 sensors) - version B
Device: ANNE™ Monitoring System (2 sensors) - version C
Registration Number
NCT04956354
Lead Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Brief Summary

The study will be conducted in a convenience sample of 75 infants admitted to the NICU at the Montreal Children's Hospital, divided into 3 phases: (a) Phase 1a - monitoring for 8h per day for 4 consecutive days, (b) Phase 1b - monitoring between 2h to 8h per day for 2 to 4 consecutive days, and (c) Phase 2- monitoring for 96h continuously.

Study objectives include:

1. Demonstrate the feasibility of continuous wireless monitoring in term and preterm infants with variable degrees of maturation and acuity in the NICU.

2. Assess safety of using a special wireless sensor system in neonates.

3. Evaluate the accuracy of proposed wireless technology as compared to standard monitoring technology in the NICU.

Detailed Description

Infants admitted in the NICU are all subject to continuous monitoring of vital signs such as heart rate, respirations and oxygen saturation (SpO2) by placing sensors, leads, or bands directly on infant's skin and connecting them to monitors via wires. However, despite the rapid technological advances in wireless monitoring and wearable devices across various industries, the health care sector has traditionally lagged. Therefore, the investigators aim to explore the safety and effectiveness of wireless monitoring (ANNE™ Monitoring System) and compare it with the traditional wired monitoring system on infants with variable degrees of maturity in the NICU.

More specifically, the investigators aim to examine (1) if it is feasible and to implement a wireless monitoring system in both term and preterm infants in the NICU; (2) if it is safe to use this particular wireless monitoring system among neonates; and (3) the accuracy of the wireless monitoring technology compared to the stand-of-care monitoring in the NICU.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
75
Inclusion Criteria
  • Healthy term infants in room air at enrollment
  • Term infants with perinatal asphyxia undergoing therapeutic hypothermia at enrollment
  • Healthy preterm infants in room air at enrollment
  • Preterm infants on continuous positive airway pressure at enrollment
  • Preterm infants on conventional mechanical ventilation at enrollment
  • Preterm infants on high frequency ventilation at enrollment
  • Preterm infants on nasal intermittent positive end expiratory pressure at enrollment
  • Preterm infants on continuous positive airway pressure at enrollment
Exclusion Criteria
  • Congenital anomalies and surgical conditions (ex: gastroschisis, omphalocele, congenital diaphragmatic hernia)
  • Congenital heart disorders
  • Congenital skin infections or known conditions with fragile skin (such as epidermolysis bullosa)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Phase 1aANNE™ Monitoring System (2 sensors) - version BOnce the setup of the study sensors is complete, clinical and physiological data will be continuously acquired for 8h during daytime, for 4 consecutive days. In addition, photographs of the skin at the site of placement of the sensors will be taken before sensors placement and after removal. Hourly axillary temperature measured by the bedside nurse (as part of routine care) will be manually recorded for each patient by the research team. A temperature and humidity recorder will also be placed around 15cm from the infants to continuously record air temperature and humidity.
Phase 1bANNE™ Monitoring System (2 sensors) - version COnce the setup of the study sensors is complete, clinical and physiological data will be continuously acquired between 2h to 8h during daytime, for 2 to 4 consecutive days. In addition, photographs of the skin at the site of placement of the sensors will be taken before sensors placement and after removal. A temperature and humidity recorder will also be placed around 15cm from the infants to continuously record air temperature and humidity.
Phase 2ANNE™ Monitoring System (2 sensors) - version COnce the setup of the study sensors is complete, clinical and physiological data will be continuously acquired for a longer monitoring period - i.e., 96 consecutive hours. In consideration with device battery life, the devices will be replaced daily. In addition, photographs of the skin at the site of placement of the sensors will be taken at baseline, device replacement, and at 96h. The research team will also measure respirations using uncalibrated RIP belts at the level of the chest and abdomen (2 to 3 continuous hours each day). Two respiratory bands will be placed circumferentially around the infant's chest and around the abdomen to measure chest and abdominal wall movements, respectively. A temperature and humidity recorder will also be placed around 15cm from the infants to continuously record air temperature and humidity.
Primary Outcome Measures
NameTimeMethod
Accuracy of wireless wearable skin temperature data4 consecutive days of wireless monitoring

Accuracy of wireless wearable skin temperature data compared against the current standards of NICU bedside monitoring.

Accuracy of wireless wearable heart rate data4 consecutive days of wireless monitoring

Accuracy of wireless wearable heart rate data compared against the current standards of NICU bedside monitoring.

Accuracy of wireless wearable respiratory rate data4 consecutive days of wireless monitoring

Accuracy of wireless wearable respiratory rate data compared against the current standards of NICU bedside monitoring.

Clinicians', nursing, and parental perceptions4 consecutive days of wireless monitoring

Clinicians', nursing, and parental perceptions of the implementation of wireless wearable devices in the NICU.

Accuracy of wireless wearable oxygen saturation (SpO2) data4 consecutive days of wireless monitoring

Accuracy of wireless wearable SpO2 data compared against the current standards of NICU bedside monitoring.

Proportion of time exhibiting unreliable wireless device signals due to significant movement artifacts4 consecutive days of wireless monitoring

Proportion of monitoring time exhibiting unreliable wireless device signals due to significant movement artifacts. The exact definition of unreliable for each of the signals will be outlined before study initiation.

Skin integrity at the sites of sensor placement4 consecutive days of wireless monitoring

Skin integrity at the site of wireless lead placements from de-identified digital photographs, evaluated by a board-certified dermatologist who will evaluate for signs of irritation, redness and/or erosions.

Proportion of time with loss of network connections or other technical problems4 consecutive days of wireless monitoring

Proportion of time with loss of network connections or other technical problems from the wireless wearables vs. the NICU bedside monitoring.

Evaluation of potential subjective pain experienced by infant at time of sensor removal4 consecutive days of wireless monitoring

Assessing infants for presence of acute pain associated with sensor removal by administering Neonatal Infant Pain Scale (NIPS) at time of device removal.

Secondary Outcome Measures
NameTimeMethod
Automated reports of physiological health - oxygen saturation4 consecutive days of wireless monitoring

Automated reports for oxygen saturation acquired from the wireless monitoring device

Enhanced respiratory monitoring using accelerometry2 to 3 consecutive hours each day during the 4-day continuous monitoring

For patients in Cohort 2, we will compare the chest and abdominal wall movement signals derived from accelerometry with thoracic impedance (the current standard) with the simultaneously recorded wireless monitoring device data.

Automated reports of physiological health - temperature4 consecutive days of wireless monitoring

Automated reports for temperature acquired from the wireless monitoring device

Automated reports of physiological health - electrocardiogram4 consecutive days of wireless monitoring

Automated reports for electrocardiogram acquired from the wireless monitoring device

Automated reports of physiological health - respiratory waveforms4 consecutive days of wireless monitoring

Automated reports for respiratory waveforms acquired from the wireless monitoring device

Comparison between chest and respiratory inductance plethysmography (RIP) and the wireless monitoring device2 to 3 consecutive hours each day during the 4-day continuous monitoring

For patients in Cohort 2, we will compare the chest and abdominal wall movement signals derived from accelerometry with RIP (the gold standard) with the simultaneously recorded wireless monitoring device data.

Trial Locations

Locations (1)

Montreal Children's Hospital

🇨🇦

Montréal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath